Arena Pharmaceuticals, Inc. (ARNA) Company Profile

Arena Pharmaceuticals, Inc. Company Snapshot

Arena Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arena Pharmaceuticals with three other companies in this sector in the United States: InterMune, Inc. (2012 sales of $26.17 million of which 100% was Pharmaceutical Products), Pharmathene Inc. ($25.18 million of which 100% was Biodefence Products), and Trius Therapeutics Incorporation ($27.19 million of which 100% was Antibiotics).

Sales Analysis. During the year ended December of 2012, sales at Arena Pharmaceuticals were $27.59 million. This is an increase of 116.9% versus 2011, when the company's sales were $12.72 million.
Business Description

Arena Pharmaceuticals, Inc.

Stock Data:

Recent Stock Performance:

Current Price (5/10/2013): 8.03
(Figures in U.S. Dollars)

1 Week	5.2%	13 Weeks	-2.3%

4 Weeks	-7.8%	52 Weeks	26.3%

Arena Pharmaceuticals, Inc. Key Data:

Ticker:	ARNA	Country:	United States

Exchanges:	NAS	Major Industry:	Pharmaceuticals & Biotechnology

		Sub Industry:	Pharmaceutical Preparations

2012 Sales	27,587,000 (Year Ending Jan 2013).	Employees:	293

Currency:	U.S. Dollars	Market Cap:	1,748,587,289

Fiscal Yr Ends:	December	Shares Outstanding:	217,756,823

Share Type:	Common	Closely Held Shares:	1,261,275

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.